The lower frequency of RAD21 gene promoter methylation in patients with monosomal karyotypes (7.7%) compared to patients with the abnormal karyotypes (24.3%) may indicate that monosomal karyotypes in AML do not favor RAD21 gene promoter methylation. The gene discussed is RAD21; the disease is acute myeloid leukemia.